CP
Healthcare & Life Sciences

Corsair Pharma

Corsair Pharma is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.

Activeseries-b
series-b
Stage
1
Investors

About Corsair Pharma

Corsair Pharma is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Corsair Pharma develops prodrug formulations of treprostinil designed for once-daily transdermal delivery to treat pulmonary arterial hypertension, aiming to improve drug administration by providing steady and consistent exposure without needles.

Explore Corsair Pharma's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States